Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul M Jordan

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
The FEBS Journal|November 6, 2021
Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infectionsPaul M Jordan, Oliver Werz
STAR Protocols|September 21, 2024
Protocol for lipid mediator profiling and phenotyping of human M1- and M2-monocyte-derived macrophages during host-pathogen interactionsKerstin Günther, Christina Ehrhardt, Oliver Werz, et al.
Frontiers in Pharmacology|September 8, 2023
Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediatorsPhilipp Dahlke, Lukas K Peltner, Paul M Jordan, et al.
ACS Applied Materials & Interfaces|December 1, 2015
On the Control of the Fixed Charge Densities in Al2O3-Based Silicon Surface Passivation SchemesDaniel K Simon, Paul M Jordan, Thomas Mikolajick, et al.
Journal of Molecular Graphics & Modelling|February 2, 2025
Discovery of novel microsomal prostaglandin E<sub>2</sub> synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening studyAbdurrahman Olğaç, Paul M Jordan, Christian Kretzer, et al.
Chembiochem : a European Journal of Chemical Biology|March 4, 2022
Synthesis of Functionalized δ-Hydroxy-β-keto Esters and Evaluation of Their Anti-inflammatory PropertiesMichel Grosse, Kerstin Günther, Paul M Jordan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 9, 2026
Analysis of lipid mediator profiles in the blood of horses with equine asthma using UPLC-MS/MSKerstin Dörsam, Vivien Nischang, Kathrin Büttner, et al.
ACS Omega|September 4, 2023
Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating ProteinAbdurrahman Olğaç, İrfan Çapan, Philipp Dahlke, et al.
Bioorganic Chemistry|September 20, 2025
Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitorsKübra Çalışkan, Mehmet Karataş, Paul M Jordan, et al.
Frontiers in Pharmacology|January 19, 2024
Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cellsVivien Nischang, Finja M Witt, Friedemann Börner, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
The FEBS Journal|November 6, 2021
Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infectionsPaul M Jordan, Oliver Werz
STAR Protocols|September 21, 2024
Protocol for lipid mediator profiling and phenotyping of human M1- and M2-monocyte-derived macrophages during host-pathogen interactionsKerstin Günther, Christina Ehrhardt, Oliver Werz, et al.
Frontiers in Pharmacology|September 8, 2023
Differential impact of 5-lipoxygenase-activating protein antagonists on the biosynthesis of leukotrienes and of specialized pro-resolving mediatorsPhilipp Dahlke, Lukas K Peltner, Paul M Jordan, et al.
ACS Applied Materials & Interfaces|December 1, 2015
On the Control of the Fixed Charge Densities in Al2O3-Based Silicon Surface Passivation SchemesDaniel K Simon, Paul M Jordan, Thomas Mikolajick, et al.
Journal of Molecular Graphics & Modelling|February 2, 2025
Discovery of novel microsomal prostaglandin E<sub>2</sub> synthase 1 (mPGES-1) inhibitors by a structurally inspired virtual screening studyAbdurrahman Olğaç, Paul M Jordan, Christian Kretzer, et al.
Chembiochem : a European Journal of Chemical Biology|March 4, 2022
Synthesis of Functionalized δ-Hydroxy-β-keto Esters and Evaluation of Their Anti-inflammatory PropertiesMichel Grosse, Kerstin Günther, Paul M Jordan, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 9, 2026
Analysis of lipid mediator profiles in the blood of horses with equine asthma using UPLC-MS/MSKerstin Dörsam, Vivien Nischang, Kathrin Büttner, et al.
ACS Omega|September 4, 2023
Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating ProteinAbdurrahman Olğaç, İrfan Çapan, Philipp Dahlke, et al.
Bioorganic Chemistry|September 20, 2025
Harnessing structure-activity relationships to repurpose the FLAP inhibitor BRP-7 into potent and selective sEH inhibitorsKübra Çalışkan, Mehmet Karataş, Paul M Jordan, et al.
Frontiers in Pharmacology|January 19, 2024
Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cellsVivien Nischang, Finja M Witt, Friedemann Börner, et al.
Pageof 8